Vol 95, No 4 (2024)
Guidelines / Expert consensus
Published online: 2024-04-11

open access

Page views 271
Article views/downloads 170
Get Citation

Connect on Social Media

Connect on Social Media

Fetal therapy guidelines of the Polish Society of Gynecologists and Obstetricians — Fetal Therapy Section

Przemyslaw Kosinski1, Dariusz Borowski2, Robert Brawura-Biskupski-Samaha3, Wojciech Cnota4, Marzena Debska5, Krzysztof Drews6, Mariusz Grzesiak78, Renata Jaczynska1, Katarzyna Janiak9, Piotr Kaczmarek9, Michal Lipa5, Magdalena Litwinska10, Katarzyna Luterek1, Anita Olejek11, Emilia Polczynska-Kaniak6, Krzysztof Preis1213, Krzysztof Szaflik9, Joanna Szymkiewicz-Dangel14, Malgorzata Swiatkowska-Freund15, Piotr Wegrzyn1, Miroslaw Wielgos516, Agata Wloch4, Jacek Zamlynski11, Mateusz Zamlynski11, Piotr Sieroszewski17
Pubmed: 38632880
Ginekol Pol 2024;95(4):285-315.

Abstract

Not available

Article available in PDF format

View PDF Download PDF file

References

  1. Dashe J, Pressman E, Hibbard J. SMFM Consult Series #46: Evaluation and management of polyhydramnios. Am J Obstet Gynecol. 2018; 219(4): B2–B8.
  2. Sagi-Dain L, Sagi S. Chromosomal aberrations in idiopathic polyhydramnios: A systematic review and meta-analysis. Eur J Med Genet. 2015; 58(8): 409–415.
  3. Bertholdt C, Fijean AL, Morel O, et al. [Postnatal outcome from polyhydramnios without sonographic abnormalities]. Gynecol Obstet Fertil Senol. 2020; 48(2): 162–166.
  4. Biesty L, Egan A, Dunne F, et al. Planned birth at or near term for improving health outcomes for pregnant women with pre-existing diabetes and their infants. Cochrane Database Syst Rev. 2018; 2018(2).
  5. Hershey DW. Fetal imaging: executive summary of a joint Eunice Kennedy Shriver National Institute of Child Health and Human Development,Society for Maternal-fetal Medicine, American Institute of Ultrasound in Medicine, American College of Obstetricians and Gynecologists, American College of Radiology, Society for Pediatric Radiology, and Society of Radiologists in Ultrasound Fetal Imaging Workshop. J Ultrasound Med. 2014; 33(10): 1876.
  6. Panting-Kemp A, Nguyen T, Castro L. Substance abuse and polyhydramnios. Am J Obstet Gynecol. 2002; 187(3): 602–605.
  7. Savage AH, Anderson BL, Simhan HN. The safety of prolonged indomethacin therapy. Am J Perinatol. 2007; 24(4): 207–213.
  8. Vermillion ST, Newman RB. Recent indomethacin tocolysis is not associated with neonatal complications in preterm infants. Am J Obstet Gynecol. 1999; 181(5 Pt 1): 1083–1086.
  9. Doyle NM, Gardner MO, Wells L, et al. Outcome of very low birth weight infants exposed to antenatal indomethacin for tocolysis. J Perinatol. 2005; 25(5): 336–340.
  10. Abou-Ghannam G, Usta IM, Nassar AH. Indomethacin in pregnancy: applications and safety. Am J Perinatol. 2012; 29(3): 175–186.
  11. Dickinson JE, Tjioe YY, Jude E, et al. Amnioreduction in the management of polyhydramnios complicating singleton pregnancies. Am J Obstet Gynecol. 2014; 211(4): 434.e1–434.e7.
  12. Suleiman A, Salim R. Mode of delivery among women admitted with polyhydramnios. J Obstet Gynaecol. 2017; 37(4): 454–458.
  13. Szaflik K. Terapia płodu. Medical Tribune Polska 2019.
  14. Moses J, Doherty DA, Magann EF, et al. A randomized clinical trial of the intrapartum assessment of amniotic fluid volume: amniotic fluid index versus the single deepest pocket technique. Am J Obstet Gynecol. 2004; 190(6): 1564–9; discussion 1569.
  15. Kacperczyk-Bartnik J, Bartnik P, Teliga-Czajkowska J, et al. Results of expectant management in singleton and twin pregnancies complicated by preterm premature rupture of membranes. Ginekol Pol. 2022; 93(12): 999–1005.
  16. Ghidini A, SChilirò M, Locatelli A. Objętość płynu owodniowego – kiedy i jakie działania należy podjąć? Ginekologia po dyplomie. 2014; 16(4): 15–24.
  17. Vikraman SK, Chandra V, Balakrishnan B, et al. Impact of antepartum diagnostic amnioinfusion on targeted ultrasound imaging of pregnancies presenting with severe oligo- and anhydramnios: An analysis of 61 cases. Eur J Obstet Gynecol Reprod Biol. 2017; 212: 96–100.
  18. Hofmeyr GJ, Kiiza JAK. Amnioinfusion for chorioamnionitis. Cochrane Database Syst Rev. 2016; 2016(8): CD011622.
  19. Hofmeyr GJ, Xu H, Eke AC. Amnioinfusion for meconium-stained liquor in labour. Cochrane Database Syst Rev. 2014; 2014(1): CD000014.
  20. Haeri S, Simon DH, Pillutla K. Serial amnioinfusions for fetal pulmonary palliation in fetuses with renal failure. J Matern Fetal Neonatal Med. 2017; 30(2): 174–176.
  21. Esaki M, Maseki Y, Tezuka A, et al. Continuous amnioinfusion in women with PPROM at periviable gestational ages. J Matern Fetal Neonatal Med. 2020; 33(7): 1151–1156.
  22. Takahashi Y, Iwagaki S, Chiaki R, et al. Amnioinfusion before 26 weeks' gestation for severe fetal growth restriction with oligohydramnios: preliminary pilot study. J Obstet Gynaecol Res. 2014; 40(3): 677–685.
  23. Sileo FG, Kulkarni A, Branescu I, et al. Non-immune fetal hydrops: etiology and outcome according to gestational age at diagnosis. Ultrasound Obstet Gynecol. 2020; 56(3): 416–421.
  24. Kosinski P, Krajewski P, Wielgos M, et al. Nonimmune Hydrops Fetalis-Prenatal Diagnosis, Genetic Investigation, Outcomes and Literature Review. J Clin Med. 2020; 9(6).
  25. Kuciel JA, Sarad JN, Kolak ML, et al. Bilateral fetal hydrothorax accompanying with absent umbilical arterial end-diastolic flow, trisomy 21 and polyhydramnios. Ginekol Pol. 2023 [Epub ahead of print].
  26. Sieroszewski P, Haus O, Zimmer M, et al. Recommendations for prenatal diagnostics of the Polish Society of Gynaecologists and Obstetricians and the Polish Society of Human Genetics. Ginekol Pol. 2022; 93(5): 427–437.
  27. Swearingen C, Colvin ZA, Leuthner SR. Nonimmune Hydrops Fetalis. Clin Perinatol. 2020; 47(1): 105–121.
  28. Mardy AH, Chetty SP, Norton ME, et al. A system-based approach to the genetic etiologies of non-immune hydrops fetalis. Prenat Diagn. 2019; 39(9): 732–750.
  29. Zwiers C, Lindenburg ITM, Klumper FJ, et al. Complications of intrauterine intravascular blood transfusion: lessons learned after 1678 procedures. Ultrasound Obstet Gynecol. 2017; 50(2): 180–186.
  30. Oepkes D, Seaward PG, Vandenbussche FP, et al. DIAMOND Study Group. Doppler ultrasonography versus amniocentesis to predict fetal anemia. N Engl J Med. 2006; 355(2): 156–164.
  31. Martinez-Portilla RJ, Lopez-Felix J, Hawkins-Villareal A, et al. Performance of fetal middle cerebral artery peak systolic velocity for prediction of anemia in untransfused and transfused fetuses: systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2019; 54(6): 722–731.
  32. Mackie FL, Hemming K, Allen S, et al. The accuracy of cell-free fetal DNA-based non-invasive prenatal testing in singleton pregnancies: a systematic review and bivariate meta-analysis. BJOG. 2017; 124(1): 32–46.
  33. Stetson B, Scrape S, Markham KB. Anti-M Alloimmunization: Management and Outcome at a Single Institution. AJP Rep. 2017; 7(4): e205–e210.
  34. Prefumo F, Fichera A, Fratelli N, et al. Fetal anemia: Diagnosis and management. Best Pract Res Clin Obstet Gynaecol. 2019; 58: 2–14.
  35. Wielgoś M, Rokicki T, Wiczyńska-Zajac A, et al. [Feto-maternal immunization and fetal hemolytic disease: invasive diagnostics and therapy in the Warsaw center of serological collision in years 1992-1999]. Ginekol Pol. 2000; 71(6): 524–531.
  36. Bousquet F, Segondy M, Faure JM, et al. B19 parvovirus-induced fetal hydrops:good outcome after intrauterine blood transfusion at 18 weeks of gestation. Fetal Diagn Ther. 2000; 15(3): 132–133.
  37. Joy SD, Rossi KQ, Krugh D, et al. Management of pregnancies complicated by anti-E alloimmunization. Obstet Gynecol. 2005; 105(1): 24–28.
  38. Deka D, Dadhwal V, Sharma A, et al. Perinatal survival and procedure-related complications after intrauterine transfusion for red cell alloimmunization. Arch Gynecol Obstet. 2015; 293(5): 967–973.
  39. Vanspranghels R, Houfflin-Debarge V, Vaast P, et al. Does an intrauterine exchange transfusion improve the fetal prognosis in parvovirus infection cases? Transfusion. 2019; 59(1): 185–190.
  40. Hellmund A, Geipel A, Berg C, et al. Early Intrauterine Transfusion in Fetuses with Severe Anemia Caused by Parvovirus B19 Infection. Fetal Diagn Ther. 2018; 43(2): 129–137.
  41. Soothill P. Intrauterine blood transfusion for non-immune hydrops fetalis due to parvovirus B19 infection. Lancet. 1990; 336(8707): 121–122.
  42. Bernaschek G, Yildiz A, Kolankaya A, et al. Complications of cordocentesis in high-risk pregnancies: effects on fetal loss or preterm delivery. Prenat Diagn. 1995; 15(11): 995–1000.
  43. Weiner C, Okamwa K. Diagnostic Fetal Blood Sampling-Technique Related Losses. Fetal Diagn Ther. 1996; 11(3): 169–175.
  44. Rao DS, Barik R. Rare presentation of intralobar pulmonary sequestration associated with repeated episodes of ventricular tachycardia. World J Cardiol. 2016; 8(7): 432–435.
  45. Durell J, Thakkar H, Gould S, et al. Pathology of asymptomatic, prenatally diagnosed cystic lung malformations. J Pediatr Surg. 2016; 51(2): 231–235.
  46. Crombleholme TM, Coleman B, Hedrick H, et al. Cystic adenomatoid malformation volume ratio predicts outcome in prenatally diagnosed cystic adenomatoid malformation of the lung. J Pediatr Surg. 2002; 37(3): 331–338.
  47. Zhang H, Tian J, Chen Z, et al. Retrospective study of prenatal diagnosed pulmonary sequestration. Pediatr Surg Int. 2014; 30(1): 47–53.
  48. Azizkhan RG, Crombleholme TM. Congenital cystic lung disease: contemporary antenatal and postnatal management. Pediatr Surg Int. 2008; 24(6): 643–657.
  49. Hubbard AM, Adzick NS, Crombleholme TM, et al. Congenital chest lesions: diagnosis and characterization with prenatal MR imaging. Radiology. 1999; 212(1): 43–48.
  50. Riley JS, Urwin JW, Oliver ER, et al. Prenatal growth characteristics and pre/postnatal management of bronchopulmonary sequestrations. J Pediatr Surg. 2018; 53(2): 265–269.
  51. Kosinski P, Tavares de Sousa M, Wielgos M, et al. Intrauterine Ultrasound-Guided Laser Coagulation of the Feeding Artery in Fetal Bronchopulmonary Sequestration. Ultraschall Med. 2017; 38(6): 583–586.
  52. Laberge JM, Flageole H, Pugash D, et al. Outcome of the prenatally diagnosed congenital cystic adenomatoid lung malformation: a Canadian experience. Fetal Diagn Ther. 2001; 16(3): 178–186.
  53. Duncombe GJ, Dickinson JE, Kikiros CS. Prenatal diagnosis and management of congenital cystic adenomatoid malformation of the lung. Am J Obstet Gynecol. 2002; 187(4): 950–954.
  54. Adzick NS, Harrison MR, Glick PL, et al. Fetal cystic adenomatoid malformation: prenatal diagnosis and natural history. J Pediatr Surg. 1985; 20(5): 483–488.
  55. Adzick NS, Flake AW, Crombleholme TM. Management of congenital lung lesions. Semin Pediatr Surg. 2003; 12(1): 10–16.
  56. Schrey S, Kelly EN, Langer JC, et al. Fetal thoracoamniotic shunting for large macrocystic congenital cystic adenomatoid malformations of the lung. Ultrasound Obstet Gynecol. 2012; 39(5): 515–520.
  57. Litwińska M, Litwińska E, Janiak K, et al. Thoracoamniotic Shunts in Macrocystic Lung Lesions: Case Series and Review of the Literature. Fetal Diagn Ther. 2017; 41(3): 179–183.
  58. Peranteau WH, Boelig MM, Khalek N, et al. Effect of single and multiple courses of maternal betamethasone on prenatal congenital lung lesion growth and fetal survival. J Pediatr Surg. 2016; 51(1): 28–32.
  59. Bermúdez C, Pérez-Wulff J, Arcadipane M, et al. Percutaneous fetal sclerotherapy for congenital cystic adenomatoid malformation of the lung. Fetal Diagn Ther. 2008; 24(3): 237–240.
  60. Kosiński P, Wielgoś M. Congenital diaphragmatic hernia: pathogenesis, prenatal diagnosis and management - literature review. Ginekol Pol. 2017; 88(1): 24–30.
  61. Keijzer R, Liu J, Deimling J, et al. Dual-hit hypothesis explains pulmonary hypoplasia in the nitrofen model of congenital diaphragmatic hernia. Am J Pathol. 2000; 156(4): 1299–1306.
  62. Nowakowska A, Sylwestrzak O, Strzelecka I, et al. Prenatal echocardiography in Trisomy 18 - the key to diagnosis and further management in the second half of pregnancy. Ginekol Pol. 2023; 94(5): 366–373.
  63. Metkus A, Filly R, Stringer M, et al. Sonographic predictors of survival in fetal diaphragmatic hernia. J Pediatr Surg. 1996; 31(1): 148–152.
  64. Deprest JA, Flemmer AW, Gratacos E, et al. Antenatal prediction of lung volume and in-utero treatment by fetal endoscopic tracheal occlusion in severe isolated congenital diaphragmatic hernia. Semin Fetal Neonatal Med. 2009; 14(1): 8–13.
  65. Peralta CF, Sbragia L, Bennini JR, et al. Fetoscopic endotracheal occlusion for severe isolated diaphragmatic hernia: initial experience from a single clinic in Brazil. Fetal Diagn Ther. 2011; 29(1): 71–77.
  66. Deprest JA, Nicolaides KH, Benachi A, et al. TOTAL Trial for Severe Hypoplasia Investigators. Randomized Trial of Fetal Surgery for Severe Left Diaphragmatic Hernia. N Engl J Med. 2021; 385(2): 107–118.
  67. Litwinska M, Litwinska E, Czaj M, et al. Ventriculo-amniotic shunting for severe fetal ventriculomegaly. Acta Obstet Gynecol Scand. 2019; 98(9): 1172–1177.
  68. Goynumer G, Yayla M, Arisoy R, et al. The criterion value of fetal cerebral lateral ventricular atrium width for diagnosis of ventriculomegaly. Clin Exp Obstet Gynecol. 2014; 41(1): 67–71.
  69. Lipa M, Kosinski P, Wojcieszak K, et al. Long-term outcomes of prenatally diagnosed ventriculomegaly - 10 years of Polish tertiary centre experience. Ginekol Pol. 2019; 90(3): 148–153.
  70. Griffiths PD, Reeves MJ, Morris JE, et al. A prospective study of fetuses with isolated ventriculomegaly investigated by antenatal sonography and in utero MR imaging. AJNR Am J Neuroradiol. 2010; 31(1): 106–111.
  71. Prefumo F, Izzi C. Fetal abdominal wall defects. Best Pract Res Clin Obstet Gynaecol. 2014; 28(3): 391–402.
  72. Jones AM, Isenburg J, Salemi JL, et al. Increasing Prevalence of Gastroschisis--14 States, 1995-2012. MMWR Morb Mortal Wkly Rep. 2016; 65(2): 23–26.
  73. Garne E, Loane M, Dolk H, et al. Prenatal diagnosis of severe structural congenital malformations in Europe. Ultrasound Obstet Gynecol. 2005; 25(1): 6–11.
  74. D'Antonio F, Virgone C, Rizzo G, et al. Prenatal Risk Factors and Outcomes in Gastroschisis: A Meta-Analysis. Pediatrics. 2015; 136(1): e159–e169.
  75. Benjamin B, Wilson GN. Anomalies associated with gastroschisis and omphalocele: analysis of 2825 cases from the Texas Birth Defects Registry. J Pediatr Surg. 2014; 49(4): 514–519.
  76. Wilson RD, Johnson MP. Congenital abdominal wall defects: an update. Fetal Diagn Ther. 2004; 19(5): 385–398.
  77. Molik KA, Gingalewski CA, West KW, et al. Gastroschisis: a plea for risk categorization. J Pediatr Surg. 2001; 36(1): 51–55.
  78. Bergholz R, Boettcher M, Reinshagen K, et al. Complex gastroschisis is a different entity to simple gastroschisis affecting morbidity and mortality-a systematic review and meta-analysis. J Pediatr Surg. 2014; 49(10): 1527–1532.
  79. Langer JC, Longaker MT, Crombleholme TM, et al. Etiology of intestinal damage in gastroschisis. I: Effects of amniotic fluid exposure and bowel constriction in a fetal lamb model. J Pediatr Surg. 1989; 24(10): 992–997.
  80. Langer JC, Bell JG, Castillo RO, et al. Etiology of intestinal damage in gastroschisis, II. Timing and reversibility of histological changes, mucosal function, and contractility. J Pediatr Surg. 1990; 25(11): 1122–1126.
  81. Cowan KN, Puligandla PS, Laberge JM, et al. Canadian Pediatric Surgery Network. The gastroschisis prognostic score: reliable outcome prediction in gastroschisis. J Pediatr Surg. 2012; 47(6): 1111–1117.
  82. Burjonrappa S, Snyder AN. Regional variation in gastroschisis: a nationwide database review of demographics and outcomes. Pediatr Surg Int. 2021; 37(7): 911–917.
  83. Ferreira RG, Mendonça CR, Gonçalves Ramos LL, et al. Gastroschisis: a systematic review of diagnosis, prognosis and treatment. J Matern Fetal Neonatal Med. 2022; 35(25): 6199–6212.
  84. Lap CC, Pistorius LR, Mulder EJH, et al. FLAMINGO Study Working Group. Ultrasound markers for prediction of complex gastroschisis and adverse outcome: longitudinal prospective nationwide cohort study. Ultrasound Obstet Gynecol. 2020; 55(6): 776–785.
  85. Youssef F, Cheong LiH, Emil S, et al. Canadian Pediatric Surgery Network (CAPSNet). Gastroschisis outcomes in North America: a comparison of Canada and the United States. J Pediatr Surg. 2016; 51(6): 891–895.
  86. Savoie K, Huang E, Aziz S, et al. Improving gastroschisis outcomes: Does birth place matter? J Pediatr Surg. 2014; 49(12): 1771–1775.
  87. Apfeld J, Kastenberg Z, Sylvester K, et al. The Effect of Level of Care on Gastroschisis Outcomes. J Pediatr. 2017; 190: 79–84.e1.
  88. Luton D, Mitanchez D, Winer N, et al. A randomised controlled trial of amnioexchange for fetal gastroschisis. BJOG. 2019; 126(10): 1233–1241.
  89. Bhide A. Amnioexchange for gastroschisis does not help, and may even harm. BJOG. 2019; 126(10): 1242.
  90. Dommergues M, Ansker Y, Aubry MC, et al. Serial transabdominal amnioinfusion in the management of gastroschisis with severe oligohydramnios. J Pediatr Surg. 1996; 31(9): 1297–1299.
  91. Sapin E, Mahieu D, Borgnon J, et al. Transabdominal amnioinfusion to avoid fetal demise and intestinal damage in fetuses with gastroschisis and severe oligohydramnios. J Pediatr Surg. 2000; 35(4): 598–600.
  92. Joyeux L, Belfort MA, De Coppi P, et al. Complex gastroschisis: a new indication for fetal surgery? Ultrasound Obstet Gynecol. 2021; 58(6): 804–812.
  93. Durmaz LO, Brunner SE, Meinzer A, et al. Fetal Surgery for Gastroschisis-A Review with Emphasis on Minimally Invasive Procedures. Children (Basel). 2022; 9(3).
  94. Willborg BE, Ibirogba ER, Trad AT, et al. Is there a role for fetal interventions in gastroschisis management? - An updated comprehensive review. Prenat Diagn. 2021; 41(1): 159–176.
  95. Oliveira GH, Acácio GL, Gonçalves RT, et al. Prenatal repair of gastroschisis using partial carbon dioxide insufflation fetoscopy: lessons learned. Einstein (Sao Paulo). 2023; 21: eRC0543.
  96. Oliveira GH, Svetliza J, Vaz-Oliani DC, et al. Novel multidisciplinary approach to monitor and treat fetuses with gastroschisis using the Svetliza Reducibility Index and the EXIT-like procedure. Einstein (Sao Paulo). 2017; 15(4): 395–402.
  97. Amin R, Domack A, Bartoletti J, et al. National Practice Patterns for Prenatal Monitoring in Gastroschisis: Gastroschisis Outcomes of Delivery (GOOD) Provider Survey. Fetal Diagn Ther. 2019; 45(2): 125–130.
  98. Overton TG, Pierce MR, Gao H, et al. Antenatal management and outcomes of gastroschisis in the U.K. Prenat Diagn. 2012; 32(13): 1256–1262.
  99. Heinig J, Müller V, Schmitz R, et al. Sonographic assessment of the extra-abdominal fetal small bowel in gastroschisis: a retrospective longitudinal study in relation to prenatal complications. Prenat Diagn. 2008; 28(2): 109–114.
  100. South A, Stutey K, Meinzen-Derr J. Metaanalysis of the prevalence of intrauterine fetal death in gastroschisis. Am J Obstet Gynecol. 2013; 209(2): 114.e1–114.e13.
  101. Kirollos DW, Abdel-Latif ME. Mode of delivery and outcomes of infants with gastroschisis: a meta-analysis of observational studies. Arch Dis Child Fetal Neonatal Ed. 2018; 103(4): F355–F363.
  102. Lopez A, Benjamin RH, Raut JR, et al. Mode of delivery and mortality among neonates with gastroschisis: A population-based cohort in Texas. Paediatr Perinat Epidemiol. 2019; 33(3): 204–212.
  103. Capone V, Persico N, Berrettini A, et al. Definition, diagnosis and management of fetal lower urinary tract obstruction: consensus of the ERKNet CAKUT-Obstructive Uropathy Work Group. Nat Rev Urol. 2022; 19(5): 295–303.
  104. Kohl T, Fimmers R, Axt-Fliedner R, et al. Vesico-amniotic shunt insertion prior to the completion of 16 weeks results in improved preservation of renal function in surviving fetuses with isolated severe lower urinary tract obstruction (LUTO). J Pediatr Urol. 2022; 18(2): 116–126.
  105. Scalabre A, Demède D, Gaillard S, et al. Prognostic Value of Ultrasound Grading Systems in Prenatally Diagnosed Unilateral Urinary Tract Dilatation. J Urol. 2017; 197(4): 1144–1149.
  106. Braga LH, McGrath M, Farrokhyar F, et al. Society for Fetal Urology Classification vs Urinary Tract Dilation Grading System for Prognostication in Prenatal Hydronephrosis: A Time to Resolution Analysis. J Urol. 2018; 199(6): 1615–1621.
  107. Maizels M, Alpert SA, Houston JTB, et al. Fetal bladder sagittal length: a simple monitor to assess normal and enlarged fetal bladder size, and forecast clinical outcome. J Urol. 2004; 172(5 Pt 1): 1995–1999.
  108. Fontanella F, Maggio L, Verheij JB, et al. Fetal megacystis: a lot more than LUTO. Ultrasound Obstet Gynecol. 2019; 53(6): 779–787.
  109. Fontanella F, van Scheltema PN, Duin L, et al. Antenatal staging of congenital lower urinary tract obstruction. Ultrasound Obstet Gynecol. 2019; 53(4): 520–524.
  110. Keefe DT, Kim JK, Mackay E, et al. Predictive accuracy of prenatal ultrasound findings for lower urinary tract obstruction: A systematic review and Bayesian meta-analysis. Prenat Diagn. 2021; 41(9): 1039–1048.
  111. Kohl T. Early 2 trimester vesico-amniotic shunt insertion promises a new era of better outcomes for fetuses with isolated severe lower urinary tract obstruction (LUTO). J Pediatr Urol. 2022; 18(2): 127–128.
  112. Monteiro S, Nassr AA, Yun PS, et al. Neurodevelopmental Outcome in Infants with Lower Urinary Tract Obstruction Based on Different Degrees of Severity. Fetal Diagn Ther. 2020; 47(8): 587–596.
  113. Strizek B, Spicher T, Gottschalk I, et al. Vesicoamniotic Shunting before 17 + 0 Weeks in Fetuses with Lower Urinary Tract Obstruction (LUTO): Comparison of Somatex vs. Harrison Shunt Systems. J Clin Med. 2022; 11(9).
  114. Cohen J, Levasseur S, Simpson L, et al. Fetal cardiac findings and hemodynamic changes associated with severe lower urinary tract obstruction in utero. Ultrasound Obstet Gynecol. 2019; 54(6): 780–785.
  115. Morris RK, Malin GL, Quinlan-Jones E, et al. The Percutaneous shunting in Lower Urinary Tract Obstruction (PLUTO) study and randomised controlled trial: evaluation of the effectiveness, cost-effectiveness and acceptability of percutaneous vesicoamniotic shunting for lower urinary tract obstruction. Health Technol Assess. 2013; 17(59): 1–232.
  116. Tkaczyk M, Stanczyk M, Krzeszowski W, et al. Neonatal survival and kidney function after prenatal interventions for obstructive uropathies. Ginekol Pol. 2019; 90(7): 416–422.
  117. Dębska M, Koleśnik A, Kretowicz P, et al. Urethroplasty with balloon catheterization in fetal lower urinary tract obstruction: observational study of 10 fetuses. Ultrasound Obstet Gynecol. 2020; 56(6): 916–920.
  118. Ruano R, Sananes N, Sangi-Haghpeykar H, et al. Fetal intervention for severe lower urinary tract obstruction: a multicenter case-control study comparing fetal cystoscopy with vesicoamniotic shunting. Ultrasound Obstet Gynecol. 2015; 45(4): 452–458.
  119. Kim M, Jung J, Han YJ, et al. P18.11: Posterior urethral valve: two cases of nephro-amniotic shunt. Ultrasound in Obstetrics & Gynecology. 2009; 34(S1): 250–250.
  120. Keil C, Bedei I, Sommer L, et al. Fetal therapy of LUTO (lower urinary tract obstruction) - a follow-up observational study. J Matern Fetal Neonatal Med. 2022; 35(25): 8536–8543.
  121. Padmanabhan R. Etiology, pathogenesis and prevention of neural tube defects. Congenit Anom (Kyoto). 2006; 46(2): 55–67.
  122. Copp A, Adzick N, Chitty L, et al. Spina bifida. Nat Rev Dis Primers. 2015; 1(1): 15007.
  123. Oakeshott P, Hunt GM, Poulton A, et al. Expectation of life and unexpected death in open spina bifida: a 40-year complete, non-selective, longitudinal cohort study. Dev Med Child Neurol. 2010; 52(8): 749–753.
  124. Svien L. Spina bifida outcome: a 25-year perspective. Pediatr Phys Ther. 2001; 13(4): 221–222.
  125. Kosinski P, Brawura Biskupski Samaha R, Lipa M, et al. Contemporary management of prenatally diagnosed spina bifida aperta - an update. Ginekol Pol. 2018; 89(11): 637–641.
  126. Lachmann R, Chaoui R, Moratalla J, et al. Posterior brain in fetuses with open spina bifida at 11 to 13 weeks. Prenat Diagn. 2011; 31(1): 103–106.
  127. Chaoui R, Benoit B, Mitkowska-Wozniak H, et al. Assessment of intracranial translucency (IT) in the detection of spina bifida at the 11-13-week scan. Ultrasound Obstet Gynecol. 2009; 34(3): 249–252.
  128. Dabrowska K, Gadzinowski J. [Are in-utero interventions justified? - perspective of neonatologists. - Part II. Spina bifida, obstructive uropathy, pleural effusion]. Ginekol Pol. 2011; 82(6): 460–467.
  129. Babcook CJ, Goldstein RB, Barth RA, et al. Prevalence of ventriculomegaly in association with myelomeningocele: correlation with gestational age and severity of posterior fossa deformity. Radiology. 1994; 190(3): 703–707.
  130. Adzick NS, Thom EA, Spong CY, et al. MOMS Investigators. A randomized trial of prenatal versus postnatal repair of myelomeningocele. N Engl J Med. 2011; 364(11): 993–1004.
  131. Tulipan N, Wellons JC, Thom EA, et al. MOMS Investigators. Prenatal surgery for myelomeningocele and the need for cerebrospinal fluid shunt placement. J Neurosurg Pediatr. 2015; 16(6): 613–620.
  132. Sacco A, Van der Veeken L, Bagshaw E, et al. Maternal complications following open and fetoscopic fetal surgery: A systematic review and meta-analysis. Prenat Diagn. 2019; 39(4): 251–268.
  133. Zamłyński J, Horzelska E, Zamłyński M, et al. Current views on fetal surgical treatment of myelomeningocele - the Management of Myelomeningocele Study (MOMS) trial and Polish clinical experience. Ginekol Pol. 2017; 88(1): 31–35.
  134. Pastuszka A, Bohosiewicz J, Olejek A, et al. In utero myelomeningocele repair reduces intensification of inflammatory changes in the dura mater and the skin. J Spinal Cord Med. 2022; 45(2): 180–185.
  135. Pastuszka A, Bohosiewicz J, Koszutski T. Prenatal myelomeningocele repair improves urinary continence and reduces the risk of constipation. Neurourol Urodyn. 2018; 37(8): 2792–2798.
  136. Sanz Cortes M, Chmait RH, Lapa DA, et al. Experience of 300 cases of prenatal fetoscopic open spina bifida repair: report of the International Fetoscopic Neural Tube Defect Repair Consortium. Am J Obstet Gynecol. 2021; 225(6): 678.e1–678.e11.
  137. Belfort MA, Whitehead WE, Shamshirsaz AA, et al. Fetoscopic Open Neural Tube Defect Repair: Development and Refinement of a Two-Port, Carbon Dioxide Insufflation Technique. Obstet Gynecol. 2017; 129(4): 734–743.
  138. Belfort MA, Whitehead WE, Shamshirsaz AA, et al. Comparison of two fetoscopic open neural tube defect repair techniques: single- vs three-layer closure. Ultrasound Obstet Gynecol. 2020; 56(4): 532–540.
  139. Corroenne R, Yepez M, Barth J, et al. Chorioamniotic membrane separation following fetal myelomeningocele repair: incidence, risk factors and impact on perinatal outcome. Ultrasound Obstet Gynecol. 2020; 56(5): 684–693.
  140. Zamłyński M, Zamłyński J, Horzelska E, et al. The Use of Indomethacin with Complete Amniotic Fluid Replacement and Classic Hysterotomy for the Reduction of Perinatal Complications of Intrauterine Myelomeningocele Repair. Fetal Diagn Ther. 2019; 46(6): 415–424.
  141. Rodriguez MA, Cass DL, Lazar DA, et al. Tumor volume to fetal weight ratio as an early prognostic classification for fetal sacrococcygeal teratoma. J Pediatr Surg. 2011; 46(6): 1182–1185.
  142. Akinkuotu AC, Coleman A, Shue E, et al. Predictors of poor prognosis in prenatally diagnosed sacrococcygeal teratoma: A multiinstitutional review. J Pediatr Surg. 2015; 50(5): 771–774.
  143. Hedrick H, Flake A, Crombleholme T, et al. Sacrococcygeal teratoma: prenatal assessment, fetal intervention, and outcome. J Pediatr Surg. 2004; 39(3): 430–438.
  144. Makin EC, Hyett J, Ade-Ajayi N, et al. Outcome of antenatally diagnosed sacrococcygeal teratomas: single-center experience (1993-2004). J Pediatr Surg. 2006; 41(2): 388–393.
  145. Lam YH, Tang MH, Shek TW. Thermocoagulation of fetal sacrococcygeal teratoma. Prenat Diagn. 2002; 22(2): 99–101.
  146. Jouannic JM, Dommergues M, Auber F, et al. Successful intrauterine shunting of a sacrococcygeal teratoma (SCT) causing fetal bladder obstruction. Prenat Diagn. 2001; 21(10): 824–826.
  147. Kontopoulos E, Chmait RH, Quintero RA. Twin-to-Twin Transfusion Syndrome: Definition, Staging, and Ultrasound Assessment. Twin Res Hum Genet. 2016; 19(3): 175–183.
  148. Lutfi S, Allen VM, Fahey J, et al. Twin-twin transfusion syndrome: a population-based study. Obstet Gynecol. 2004; 104(6): 1289–1297.
  149. Bamberg C, Hecher K. Update on twin-to-twin transfusion syndrome. Best Pract Res Clin Obstet Gynaecol. 2019; 58: 55–65.
  150. Dekoninck P, Deprest J, Lewi P, et al. Gestational age-specific reference ranges for amniotic fluid assessment in monochorionic diamniotic twin pregnancies. Ultrasound Obstet Gynecol. 2013; 41(6): 649–652.
  151. Quintero RA, Morales WJ, Allen MH, et al. Staging of twin-twin transfusion syndrome. J Perinatol. 1999; 19(8 Pt 1): 550–555.
  152. Wielgos M, Bomba-Opoń D, Breborowicz GH, et al. Recommendations of the Polish Society of Gynecologists and Obstetricians regarding caesarean sections. Ginekol Pol. 2018; 89(11): 644–657.
  153. Carr SR, Luks F, Tracy T, et al. Antenatal necrotic injury in severe twin-to-twin transfusion syndrome. A case and review. Fetal Diagn Ther. 2004; 19(4): 370–372.
  154. Schrey S, Huber A, Hecher K, et al. Vascular limb occlusion in twin-twin transfusion syndrome (TTTS): case series and literature review. Am J Obstet Gynecol. 2012; 207(2): 131.e1–131.10.
  155. Majewska A, Brawura-Biskupski-Samaha R, Kozłowski S, et al. Twin-to-twin transfusion syndrome complicated with in utero limb ischemia of the donor twin - a case report. BMC Pregnancy Childbirth. 2022; 22(1): 97.
  156. Senat MV, Deprest J, Boulvain M, et al. Endoscopic laser surgery versus serial amnioreduction for severe twin-to-twin transfusion syndrome. N Engl J Med. 2004; 351(2): 136–144.
  157. Stirnemann J, Slaghekke F, Khalek N, et al. Intrauterine fetoscopic laser surgery versus expectant management in stage 1 twin-to-twin transfusion syndrome: an international randomized trial. Am J Obstet Gynecol. 2021; 224(5): 528.e1–528.e12.
  158. Baud D, Windrim R, Keunen J, et al. Fetoscopic laser therapy for twin-twin transfusion syndrome before 17 and after 26 weeks' gestation. Am J Obstet Gynecol. 2013; 208(3): 197.e1–197.e7.
  159. Valsky DV, Eixarch E, Martinez-Crespo JM, et al. Fetoscopic laser surgery for twin-to-twin transfusion syndrome after 26 weeks of gestation. Fetal Diagn Ther. 2012; 31(1): 30–34.
  160. Middeldorp JM, Lopriore E, Sueters M, et al. Twin-to-twin transfusion syndrome after 26 weeks of gestation: is there a role for fetoscopic laser surgery? BJOG. 2007; 114(6): 694–698.
  161. Gandhi M, Papanna R, Moise K, et al. Treatment of twin-twin transfusion syndrome with proximate umbilical cord insertions. J Ultrasound Med. 2011; 30(8): 1151–1155.
  162. Roberts D, Neilson JP, Kilby MD, et al. Interventions for the treatment of twin-twin transfusion syndrome. Cochrane Database Syst Rev. 2001; 31(1): CD002073–711.
  163. Roberts D, Gates S, Kilby M, et al. Interventions for twin-twin transfusion syndrome: a Cochrane review. Ultrasound Obstet Gynecol. 2008; 31(6): 701–711.
  164. Merz W, Tchatcheva K, Gembruch U, et al. Maternal complications of fetoscopic laser photocoagulation (FLP) for treatment of twin-twin transfusion syndrome (TTTS). J Perinat Med. 2010; 38(4): 439–443.
  165. Zhang LY, Wei X, Zou G, et al. [Perioperative maternal complications of twin-twin transfusion syndrome after fetoscopic laser photocoagulation]. Zhonghua Fu Chan Ke Za Zhi. 2020; 55(12): 823–829.
  166. Khalil A, Rodgers M, Baschat A, et al. ISUOG Practice Guidelines: role of ultrasound in twin pregnancy. Ultrasound Obstet Gynecol. 2016; 47(2): 247–263.
  167. Townsend R, D'Antonio F, Sileo FG, et al. Perinatal outcome of monochorionic twin pregnancy complicated by selective fetal growth restriction according to management: systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2019; 53(1): 36–46.
  168. Khalil A, Beune I, Hecher K, et al. Consensus definition and essential reporting parameters of selective fetal growth restriction in twin pregnancy: a Delphi procedure. Ultrasound Obstet Gynecol. 2019; 53(1): 47–54.
  169. Khalil A, Thilaganathan B. Selective fetal growth restriction in monochorionic twin pregnancy: a dilemma for clinicians and a challenge for researchers. Ultrasound Obstet Gynecol. 2019; 53(1): 23–25.
  170. Gratacós E, Lewi L, Muñoz B, et al. A classification system for selective intrauterine growth restriction in monochorionic pregnancies according to umbilical artery Doppler flow in the smaller twin. Ultrasound Obstet Gynecol. 2007; 30(1): 28–34.
  171. Buca D, Pagani G, Rizzo G, et al. Outcome of monochorionic twin pregnancy with selective intrauterine growth restriction according to umbilical artery Doppler flow pattern of smaller twin: systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2017; 50(5): 559–568.
  172. van Gemert MJC, van den Wijngaard JP, Vandenbussche FP. Twin reversed arterial perfusion sequence is more common than generally accepted. Birth Defects Res A Clin Mol Teratol. 2015; 103(7): 641–643.
  173. Chaveeva P, Poon LC, Sotiriadis A, et al. Optimal method and timing of intrauterine intervention in twin reversed arterial perfusion sequence: case study and meta-analysis. Fetal Diagn Ther. 2014; 35(4): 267–279.
  174. Tavares de Sousa M, Glosemeyer P, Diemert A, et al. First-trimester intervention in twin reversed arterial perfusion sequence. Ultrasound Obstet Gynecol. 2020; 55(1): 47–49.
  175. Wegrzyn P, Borowski D, Nowacka E, et al. [Interstitial laser coagulation in Twin Reversed Arterial Perfusion sequence]. Ginekol Pol. 2012; 83(11): 865–870.
  176. Lewi L, Valencia C, Gonzalez E, et al. The outcome of twin reversed arterial perfusion sequence diagnosed in the first trimester. Am J Obstet Gynecol. 2010; 203(3): 213.e1–213.e4.
  177. Weber EC, Recker F, Gottschalk I, et al. Outcome of Monochorionic Monoamniotic Twin Reversed Arterial Perfusion Sequence Diagnosed in the First Trimester. Fetal Diagn Ther. 2021; 48(11-12): 778–784.
  178. Lopriore E, Slaghekke F, Oepkes D, et al. Hematological characteristics in neonates with twin anemia-polycythemia sequence (TAPS). Prenat Diagn. 2010; 30(3): 251–255.
  179. Kaluba-Skotarczak A, Ropacka-Lesiak M, Drews K, et al. [TAPS sequence--unknown and underestimated problem of monochorionic pregnancies]. Ginekol Pol. 2013; 84(3): 223–228.
  180. Ashwal E, Yinon Y, Fishel-Bartal M, et al. Twin Anemia-Polycythemia Sequence: Perinatal Management and Outcome. Fetal Diagn Ther. 2016; 40(1): 28–34.
  181. Sananès N, Veujoz M, Severac F, et al. Evaluation of the Utility of in utero Treatment of Twin Anemia-Polycythemia Sequence. Fetal Diagn Ther. 2015; 38(3): 170–178.
  182. Verbeek L, Slaghekke F, Favre R, et al. Short-Term Postnatal Renal Function in Twin Anemia-Polycythemia Sequence. Fetal Diagn Ther. 2016; 39(3): 192–197.
  183. Giorgione V, D'antonio F, Manji A, et al. Perinatal outcome of pregnancy complicated by twin anemia-polycythemia sequence: systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2021; 58(6): 813–823.
  184. Kirkham FJ, Zafeiriou D, Howe D, et al. Fetal stroke and cerebrovascular disease: Advances in understanding from lenticulostriate and venous imaging, alloimmune thrombocytopaenia and monochorionic twins. Eur J Paediatr Neurol. 2018; 22(6): 989–1005.
  185. Tollenaar LSA, Slaghekke F, Lewi L, et al. Collaborators. Treatment and outcome of 370 cases with spontaneous or post-laser twin anemia-polycythemia sequence managed in 17 fetal therapy centers. Ultrasound Obstet Gynecol. 2020; 56(3): 378–387.
  186. von Kaisenberg C, Klaritsch P, Ochsenbein-Kölble N, et al. Screening, Management and Delivery in Twin Pregnancy. Ultraschall Med. 2021; 42(4): 367–378.
  187. Tollenaar LSA, Lopriore E, Slaghekke F, et al. High risk of long-term neurodevelopmental impairment in donor twins with spontaneous twin anemia-polycythemia sequence. Ultrasound Obstet Gynecol. 2020; 55(1): 39–46.